<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113762.1.4.1164.30" displayName="Bisphosphonates for osteoporosis treatment with non metastatic prostate cancer" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="1020064" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="risedronate sodium 35 MG Delayed Release Oral Tablet"/>            <ns0:Concept code="1114085" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="100 ML zoledronic acid 0.04 MG/ML Injection"/>            <ns0:Concept code="1248077" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Alendronic acid 70 MG Effervescent Oral Tablet"/>            <ns0:Concept code="1435115" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="28 ACTUAT Teriparatide 0.02 MG/ACTUAT Pen Injector"/>            <ns0:Concept code="1865665" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="zoledronic acid 4 MG Injection"/>            <ns0:Concept code="351114" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="5 ML zoledronic acid 0.8 MG/ML Injection"/>            <ns0:Concept code="705824" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="100 ML zoledronic acid 0.05 MG/ML Injection"/>            <ns0:Concept code="904419" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Alendronic acid 10 MG Oral Tablet"/>            <ns0:Concept code="904431" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Alendronic acid 70 MG Oral Tablet"/>            <ns0:Concept code="904462" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Alendronic acid 70 MG / Cholecalciferol 5600 UNT Oral Tablet"/>            <ns0:Concept code="904492" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Alendronic acid 70 MG / Cholecalciferol 2800 UNT Oral Tablet"/>            <ns0:Concept code="905024" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="risedronate sodium 35 MG Oral Tablet"/>        </ns0:ConceptList>        <ns0:Source>Large Urology Group Practice Association </ns0:Source>        <ns0:Purpose>(Clinical Focus: This set of values contains bisphosphonates that are prescribed for osteoporosis in men with prostate cancer that is non metastatic to bone.),(Data Element Scope: The intent of this data elemnt is to identify bisphosphonates for treatment of osteoporosis in men with prostate cancer that is not metastatic to the bone.),(Inclusion Criteria: Bisphosphonates for use with men with osteoporosis),(Exclusion Criteria: Bisphosphonates not approved for men with prostate cancer on androgen deprivation therapy)</ns0:Purpose>        <ns0:Type>Extensional</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2017-06-21</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>